订阅小程序
旧版功能

Development and IND-enabling Studies of a Novel Cas9 Genome-Edited Autologous CD34+ Cell Therapy to Induce Fetal Hemoglobin for Sickle Cell Disease

Molecular Therapy(2024)

引用 0|浏览28
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要